Gastric Cancer RAD001 Study
NCT01514110
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
RAD001
Sponsor
Chinese University of Hong Kong